During the past decade, Zhongshan People's Hospital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.8% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 1 clinical trials were completed. i.e. 5.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zhongshan People's Hospital" #1 sponsor was "Sun Yat-sen University" with 6 trials, followed by "Leo Wang" with 3 trials sponsored, "Nanfang Hospital of Southern Medical University" with 3 trials sponsored, "Third Affiliated Hospital, Sun Yat-Sen University" with 3 trials sponsored and "Zhongshan People's Hospital, Guangdong, China" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zhongshan People's Hospital" #1 collaborator was "Zhongshan People's Hospital, Guangdong, China" with 9 trials as a collaborator, "Fifth Affiliated Hospital, Sun Yat-Sen University" with 4 trials as a collaborator, "First Affiliated Hospital, Sun Yat-Sen University" with 4 trials as a collaborator, "First People's Hospital of Foshan" with 4 trials as a collaborator and "Wuzhou Red Cross Hospital" with 4 trials as a collaborator. Other collaborators include 91 different institutions and companies that were collaborators in the rest 82 trials.

According to Clinical.Site data, the most researched conditions in "Zhongshan People's Hospital" are "Nasopharyngeal Carcinoma" (6 trials), "Chemotherapy" (3 trials), "Chronic Hepatitis C" (3 trials), "Hypertension" (3 trials) and "Radiotherapy" (3 trials). Many other conditions were trialed in "Zhongshan People's Hospital" in a lesser frequency.

Most popular intervention types in "Zhongshan People's Hospital" are "Drug" (21 trials), "Device" (5 trials), "Procedure" (5 trials), "Radiation" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (3 trials), "Peginterferon alfa2a" (3 trials), "Ribavirin" (3 trials), "Paclitaxel" (2 trials) and "Quality-of-Life Assessment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Zhongshan People's Hospital" are 35 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Zhongshan People's Hospital". undefined are not yet recruiting, 19 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Zhongshan People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zhongshan People's Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 7 trials that are defined as “Not Applicable".